TOVX 8-K 2026-11-12

Theriva Biologics, Inc. (TOVX) 8-K dated 2026-11-12 — accession 0001104659-26-125912.

Theriva Biologics, Inc. (TOVX) is a biotechnology company listed on NYSE MKT.

Theriva Biologics, Inc. filed a 8-K on 2026-11-12. Accession 0001104659-26-125912.

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported TOVX revenue for 2026-03-31 was $300.0K. Net income was -$2.0M. TOVX currently screens at market cap $12.4M.

Not investment advice. The TOVX SEC hub lists recent forms. The stock page is the research view.